Nano-drug delivery systems integrated with low radiation doses for enhanced therapeutic efficacy in cancer treatment
Due to the poor prognosis associated with GBM, new therapeutic approaches are necessary. There is an increasing interest in precision medicine, which includes nanomedicine and radiotherapy, for GBM treatment<b>.</b> This integration enhances the efficacy of targeted treatments and provides a promising avenue for reducing adverse effects, signifying a notable advancement in precision oncology.
Authors
- Filippo Flavio Angileri (ORCID: https://orcid.org/0000-0002-1107-4115)
- Salvatore Lavalle (ORCID: https://orcid.org/0009-0009-5556-6259)
- Marco Zeppieri (ORCID: https://orcid.org/0000-0003-0999-5545)
- Maria Caffo (ORCID: https://orcid.org/0000-0002-3240-0506)
- Stefano Pergolizzi (ORCID: https://orcid.org/0000-0002-4696-7634)
- Paola Critelli (ORCID: https://orcid.org/0000-0003-1381-7012)
- Antonio Pontoriero (ORCID: https://orcid.org/0000-0003-3011-6779)
- Silvana Parisi (ORCID: https://orcid.org/0000-0001-9135-1639)
- Alberto Bosurgi
- S. Guercio
Institutions
- University of Messina (IT)
- University of Udine (IT)
- Università degli Studi di Enna Kore (IT)
Publication Details
- Journal
- World Journal of Clinical Cases
- Published
- 2024-12-18
- DOI
- https://doi.org/10.12998/wjcc.v13.i10.101719
- Citations
- 2
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.37